| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Body | 134 | 2026 | 246 | 27.770 |
Why?
|
| Hypoxia | 153 | 2026 | 699 | 24.530 |
Why?
|
| Oxygen | 68 | 2026 | 802 | 9.470 |
Why?
|
| Reactive Oxygen Species | 47 | 2022 | 525 | 6.020 |
Why?
|
| Hydrogen Sulfide | 17 | 2025 | 54 | 5.910 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 29 | 2026 | 176 | 5.190 |
Why?
|
| Hypertension | 16 | 2025 | 778 | 4.510 |
Why?
|
| Sleep Apnea Syndromes | 18 | 2023 | 109 | 4.430 |
Why?
|
| Adrenal Medulla | 17 | 2024 | 49 | 4.210 |
Why?
|
| Chemoreceptor Cells | 42 | 2019 | 65 | 4.080 |
Why?
|
| Respiration | 41 | 2026 | 274 | 3.790 |
Why?
|
| Animals | 233 | 2026 | 28904 | 3.540 |
Why?
|
| Rats | 85 | 2025 | 4071 | 3.510 |
Why?
|
| Hypoxia-Inducible Factor 1 | 14 | 2026 | 43 | 3.470 |
Why?
|
| Sympathetic Nervous System | 17 | 2025 | 100 | 3.440 |
Why?
|
| Cell Hypoxia | 31 | 2022 | 191 | 3.210 |
Why?
|
| Sleep Apnea, Obstructive | 10 | 2024 | 229 | 3.200 |
Why?
|
| Chromaffin Cells | 12 | 2021 | 36 | 3.160 |
Why?
|
| Carbon Monoxide | 16 | 2022 | 98 | 3.130 |
Why?
|
| Catecholamines | 15 | 2021 | 94 | 3.080 |
Why?
|
| Rats, Sprague-Dawley | 52 | 2025 | 1255 | 3.030 |
Why?
|
| Cystathionine gamma-Lyase | 10 | 2021 | 35 | 2.750 |
Why?
|
| Receptors, Odorant | 4 | 2023 | 38 | 2.660 |
Why?
|
| Oxidative Stress | 16 | 2015 | 489 | 2.660 |
Why?
|
| Reflex | 14 | 2022 | 82 | 2.520 |
Why?
|
| NADPH Oxidases | 10 | 2015 | 87 | 2.470 |
Why?
|
| Calcium | 26 | 2025 | 1196 | 2.420 |
Why?
|
| Heme Oxygenase (Decyclizing) | 13 | 2021 | 46 | 2.280 |
Why?
|
| Signal Transduction | 25 | 2025 | 3620 | 2.260 |
Why?
|
| Apnea | 9 | 2026 | 36 | 2.210 |
Why?
|
| Analgesics, Opioid | 3 | 2026 | 540 | 1.940 |
Why?
|
| Fentanyl | 2 | 2025 | 92 | 1.700 |
Why?
|
| Mice | 49 | 2026 | 12706 | 1.570 |
Why?
|
| Blood Pressure | 34 | 2018 | 910 | 1.560 |
Why?
|
| PC12 Cells | 26 | 2021 | 112 | 1.550 |
Why?
|
| Respiratory Insufficiency | 2 | 2026 | 211 | 1.520 |
Why?
|
| Erythropoietin | 2 | 2024 | 90 | 1.490 |
Why?
|
| Epigenesis, Genetic | 8 | 2020 | 588 | 1.490 |
Why?
|
| Mice, Knockout | 24 | 2025 | 2209 | 1.440 |
Why?
|
| Animals, Newborn | 15 | 2019 | 524 | 1.400 |
Why?
|
| Substance P | 17 | 2011 | 62 | 1.380 |
Why?
|
| Gasotransmitters | 5 | 2023 | 14 | 1.350 |
Why?
|
| Gases | 4 | 2018 | 31 | 1.350 |
Why?
|
| Respiratory Mechanics | 7 | 2013 | 109 | 1.340 |
Why?
|
| Peripheral Nervous System | 4 | 2026 | 21 | 1.340 |
Why?
|
| Neuronal Plasticity | 10 | 2013 | 200 | 1.290 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 3603 | 1.270 |
Why?
|
| Calcium Channels, T-Type | 3 | 2015 | 24 | 1.210 |
Why?
|
| Calcium Signaling | 3 | 2025 | 142 | 1.200 |
Why?
|
| Male | 105 | 2026 | 47077 | 1.190 |
Why?
|
| Nitric Oxide Synthase | 13 | 2012 | 124 | 1.170 |
Why?
|
| Nitric Oxide | 14 | 2012 | 286 | 1.150 |
Why?
|
| Gene Expression Regulation | 16 | 2017 | 2023 | 1.140 |
Why?
|
| Receptors, Opioid, kappa | 2 | 2025 | 21 | 1.120 |
Why?
|
| Phrenic Nerve | 22 | 2018 | 49 | 1.120 |
Why?
|
| Norepinephrine | 10 | 2024 | 167 | 1.080 |
Why?
|
| DNA Methylation | 6 | 2018 | 730 | 1.040 |
Why?
|
| Hyperoxia | 2 | 2026 | 38 | 1.020 |
Why?
|
| Epinephrine | 4 | 2024 | 91 | 1.020 |
Why?
|
| Calcium Channels | 10 | 2014 | 180 | 1.010 |
Why?
|
| Oxygen Consumption | 16 | 2017 | 239 | 1.000 |
Why?
|
| Physiology | 3 | 2020 | 17 | 0.990 |
Why?
|
| Disease Models, Animal | 13 | 2021 | 2573 | 0.980 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 7 | 2019 | 23 | 0.950 |
Why?
|
| Sensory Receptor Cells | 2 | 2018 | 40 | 0.950 |
Why?
|
| Carbon Dioxide | 19 | 2022 | 202 | 0.920 |
Why?
|
| Medicine | 2 | 2020 | 95 | 0.910 |
Why?
|
| Humans | 92 | 2026 | 98088 | 0.900 |
Why?
|
| Respiration Disorders | 3 | 2016 | 42 | 0.900 |
Why?
|
| Hypoxia, Brain | 3 | 2014 | 41 | 0.900 |
Why?
|
| Protein Processing, Post-Translational | 8 | 2015 | 412 | 0.870 |
Why?
|
| Pheochromocytoma | 2 | 2024 | 53 | 0.870 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2024 | 39 | 0.860 |
Why?
|
| Mitochondria | 10 | 2013 | 650 | 0.840 |
Why?
|
| Homeostasis | 9 | 2017 | 474 | 0.840 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2024 | 84 | 0.840 |
Why?
|
| Xanthine Oxidase | 2 | 2015 | 25 | 0.840 |
Why?
|
| Transcriptional Activation | 8 | 2024 | 293 | 0.830 |
Why?
|
| Chronic Disease | 13 | 2021 | 985 | 0.780 |
Why?
|
| Membrane Glycoproteins | 4 | 2015 | 446 | 0.770 |
Why?
|
| Lung | 5 | 2015 | 1407 | 0.740 |
Why?
|
| Carotid Sinus | 11 | 2015 | 19 | 0.740 |
Why?
|
| Carbonic Anhydrases | 1 | 2022 | 16 | 0.730 |
Why?
|
| Oxidation-Reduction | 6 | 2016 | 419 | 0.730 |
Why?
|
| Enzyme Activation | 14 | 2015 | 679 | 0.720 |
Why?
|
| Cats | 41 | 2008 | 281 | 0.700 |
Why?
|
| Neurons, Afferent | 7 | 2008 | 72 | 0.690 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 15 | 0.680 |
Why?
|
| Tyrosine 3-Monooxygenase | 9 | 2012 | 41 | 0.680 |
Why?
|
| Genes, fos | 8 | 2004 | 24 | 0.680 |
Why?
|
| Respiratory Physiological Phenomena | 5 | 2006 | 50 | 0.640 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 20 | 0.630 |
Why?
|
| Nobel Prize | 1 | 2020 | 10 | 0.620 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2020 | 17 | 0.620 |
Why?
|
| Serotonin | 5 | 2011 | 211 | 0.620 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2014 | 215 | 0.620 |
Why?
|
| Calcium Channel Blockers | 10 | 2012 | 118 | 0.610 |
Why?
|
| Neurotransmitter Agents | 7 | 2014 | 102 | 0.610 |
Why?
|
| Inflammation | 1 | 2026 | 1120 | 0.610 |
Why?
|
| Cells, Cultured | 16 | 2018 | 2855 | 0.600 |
Why?
|
| Potassium Channels | 8 | 2005 | 349 | 0.600 |
Why?
|
| Electron Transport Complex I | 4 | 2018 | 36 | 0.600 |
Why?
|
| Hypercapnia | 10 | 2022 | 51 | 0.600 |
Why?
|
| Calcium Channels, L-Type | 6 | 2002 | 38 | 0.590 |
Why?
|
| Enzyme Inhibitors | 16 | 2012 | 642 | 0.590 |
Why?
|
| Protein Kinase C | 8 | 2015 | 267 | 0.580 |
Why?
|
| Ion Channels | 3 | 2014 | 259 | 0.580 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 1133 | 0.560 |
Why?
|
| Proto-Oncogene Proteins c-fos | 4 | 2005 | 66 | 0.560 |
Why?
|
| Sulfites | 1 | 2018 | 37 | 0.550 |
Why?
|
| Transcription Factors | 7 | 2024 | 1717 | 0.550 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 400 | 0.550 |
Why?
|
| In Vitro Techniques | 20 | 2012 | 945 | 0.520 |
Why?
|
| Endothelin-1 | 3 | 2013 | 42 | 0.510 |
Why?
|
| Second Messenger Systems | 3 | 2012 | 39 | 0.510 |
Why?
|
| HEK293 Cells | 5 | 2025 | 721 | 0.500 |
Why?
|
| Action Potentials | 14 | 2018 | 611 | 0.490 |
Why?
|
| Sensation | 1 | 2017 | 48 | 0.490 |
Why?
|
| Calpain | 3 | 2015 | 113 | 0.490 |
Why?
|
| Phosphorylation | 9 | 2015 | 1145 | 0.480 |
Why?
|
| Respiratory System | 6 | 2016 | 121 | 0.480 |
Why?
|
| Arteries | 3 | 2015 | 171 | 0.480 |
Why?
|
| Rabbits | 19 | 2007 | 581 | 0.470 |
Why?
|
| Vagus Nerve | 5 | 2008 | 46 | 0.460 |
Why?
|
| Superoxide Dismutase | 6 | 2016 | 155 | 0.460 |
Why?
|
| Cation Transport Proteins | 3 | 2001 | 65 | 0.460 |
Why?
|
| RNA, Messenger | 11 | 2022 | 2063 | 0.460 |
Why?
|
| Adaptation, Physiological | 5 | 2012 | 349 | 0.460 |
Why?
|
| Genes, Immediate-Early | 4 | 2004 | 17 | 0.450 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2015 | 17 | 0.450 |
Why?
|
| Potassium Channels, Voltage-Gated | 3 | 2001 | 115 | 0.450 |
Why?
|
| Dopamine | 11 | 2019 | 280 | 0.440 |
Why?
|
| Transcription Factor AP-1 | 5 | 2005 | 68 | 0.440 |
Why?
|
| Arterial Pressure | 1 | 2015 | 44 | 0.430 |
Why?
|
| Respiratory Muscles | 5 | 2008 | 27 | 0.420 |
Why?
|
| Angiotensin II | 2 | 2012 | 98 | 0.420 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2014 | 3 | 0.420 |
Why?
|
| Neprilysin | 4 | 2000 | 39 | 0.410 |
Why?
|
| Protein Kinases | 5 | 2012 | 212 | 0.410 |
Why?
|
| Long-Term Potentiation | 4 | 2011 | 51 | 0.410 |
Why?
|
| Cardiovascular System | 4 | 2013 | 52 | 0.400 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 56 | 0.400 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 100 | 0.390 |
Why?
|
| Metalloendopeptidases | 1 | 2013 | 44 | 0.390 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2013 | 69 | 0.390 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 802 | 0.390 |
Why?
|
| Endothelial Cells | 3 | 2022 | 500 | 0.380 |
Why?
|
| Medulla Oblongata | 17 | 2023 | 92 | 0.380 |
Why?
|
| Nerve Net | 2 | 2015 | 401 | 0.380 |
Why?
|
| Pressoreceptors | 2 | 2011 | 12 | 0.370 |
Why?
|
| Endothelins | 2 | 2010 | 26 | 0.370 |
Why?
|
| Energy Metabolism | 2 | 2017 | 315 | 0.370 |
Why?
|
| Acetylcholine | 8 | 2014 | 158 | 0.370 |
Why?
|
| Fetal Hypoxia | 1 | 2012 | 14 | 0.370 |
Why?
|
| Up-Regulation | 8 | 2015 | 743 | 0.370 |
Why?
|
| Time Factors | 16 | 2014 | 5567 | 0.370 |
Why?
|
| Pulmonary Ventilation | 4 | 2012 | 32 | 0.360 |
Why?
|
| Central Nervous System | 3 | 2011 | 144 | 0.350 |
Why?
|
| Academies and Institutes | 1 | 2011 | 35 | 0.350 |
Why?
|
| DNA-Binding Proteins | 5 | 2014 | 1255 | 0.350 |
Why?
|
| Molecular Biology | 1 | 2012 | 83 | 0.340 |
Why?
|
| Heart | 3 | 2012 | 527 | 0.340 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 4 | 2004 | 85 | 0.340 |
Why?
|
| Immunohistochemistry | 8 | 2018 | 1815 | 0.340 |
Why?
|
| NADPH Oxidase 4 | 2 | 2021 | 15 | 0.330 |
Why?
|
| Acclimatization | 3 | 2009 | 91 | 0.330 |
Why?
|
| Antioxidants | 7 | 2013 | 236 | 0.330 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2019 | 45 | 0.330 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2010 | 9 | 0.330 |
Why?
|
| Universities | 1 | 2011 | 166 | 0.330 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2010 | 24 | 0.320 |
Why?
|
| Tachykinins | 3 | 2003 | 14 | 0.320 |
Why?
|
| NADPH Oxidase 2 | 4 | 2015 | 23 | 0.320 |
Why?
|
| Patch-Clamp Techniques | 9 | 2011 | 381 | 0.320 |
Why?
|
| Membrane Potentials | 9 | 2010 | 406 | 0.310 |
Why?
|
| Exocytosis | 1 | 2010 | 109 | 0.310 |
Why?
|
| Brain Stem | 8 | 2018 | 167 | 0.310 |
Why?
|
| Respiratory Center | 2 | 2011 | 52 | 0.300 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 5 | 2000 | 12 | 0.300 |
Why?
|
| Gene Expression | 7 | 2016 | 1320 | 0.300 |
Why?
|
| Protein Transport | 4 | 2019 | 448 | 0.300 |
Why?
|
| Receptors, Nicotinic | 1 | 2010 | 133 | 0.300 |
Why?
|
| Laboratory Animal Science | 1 | 2009 | 8 | 0.300 |
Why?
|
| Metalloporphyrins | 6 | 2013 | 26 | 0.300 |
Why?
|
| Superoxides | 4 | 2012 | 76 | 0.290 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 2 | 2009 | 14 | 0.290 |
Why?
|
| Electrophysiology | 7 | 2006 | 384 | 0.290 |
Why?
|
| Telemetry | 1 | 2009 | 30 | 0.290 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2008 | 10 | 0.290 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2006 | 38 | 0.290 |
Why?
|
| GTP-Binding Proteins | 3 | 2000 | 150 | 0.280 |
Why?
|
| Blood Pressure Determination | 1 | 2009 | 72 | 0.280 |
Why?
|
| Infant, Premature | 2 | 2026 | 305 | 0.280 |
Why?
|
| Nerve Tissue Proteins | 3 | 1996 | 512 | 0.280 |
Why?
|
| Partial Pressure | 9 | 2012 | 47 | 0.280 |
Why?
|
| Hydrogen Peroxide | 5 | 2020 | 173 | 0.270 |
Why?
|
| Cyclic GMP | 5 | 1999 | 63 | 0.270 |
Why?
|
| Infant, Newborn | 4 | 2026 | 2529 | 0.270 |
Why?
|
| History, 21st Century | 3 | 2020 | 196 | 0.260 |
Why?
|
| Potassium Chloride | 4 | 2012 | 75 | 0.260 |
Why?
|
| Neurons | 8 | 2011 | 1619 | 0.260 |
Why?
|
| Brain | 8 | 2018 | 2430 | 0.260 |
Why?
|
| Female | 44 | 2021 | 51541 | 0.260 |
Why?
|
| Models, Biological | 8 | 2020 | 1807 | 0.250 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2007 | 19 | 0.250 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 1605 | 0.250 |
Why?
|
| Baroreflex | 2 | 2020 | 8 | 0.250 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2006 | 33 | 0.240 |
Why?
|
| Afferent Pathways | 5 | 2005 | 61 | 0.230 |
Why?
|
| Cyclic AMP | 2 | 2025 | 277 | 0.230 |
Why?
|
| Biphenyl Compounds | 3 | 2000 | 63 | 0.230 |
Why?
|
| Regional Blood Flow | 3 | 2017 | 194 | 0.230 |
Why?
|
| Alkynes | 2 | 2018 | 20 | 0.230 |
Why?
|
| Adenosine Triphosphate | 3 | 2014 | 319 | 0.230 |
Why?
|
| Models, Cardiovascular | 2 | 2017 | 96 | 0.230 |
Why?
|
| Motor Neurons | 6 | 2023 | 192 | 0.220 |
Why?
|
| Hemeproteins | 2 | 2005 | 17 | 0.220 |
Why?
|
| Insulin | 4 | 2020 | 1225 | 0.220 |
Why?
|
| Glycine | 2 | 2018 | 96 | 0.220 |
Why?
|
| Malondialdehyde | 3 | 2016 | 27 | 0.220 |
Why?
|
| Trans-Activators | 3 | 2004 | 447 | 0.220 |
Why?
|
| Free Radical Scavengers | 1 | 2005 | 59 | 0.220 |
Why?
|
| Benzazepines | 3 | 2021 | 64 | 0.210 |
Why?
|
| Altitude | 2 | 2002 | 53 | 0.210 |
Why?
|
| Adenylyl Cyclases | 1 | 2025 | 105 | 0.210 |
Why?
|
| Transfection | 3 | 2021 | 883 | 0.210 |
Why?
|
| Down-Regulation | 4 | 2010 | 529 | 0.210 |
Why?
|
| Electrochemistry | 3 | 2010 | 60 | 0.210 |
Why?
|
| Bicarbonates | 2 | 2001 | 60 | 0.210 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2002 | 488 | 0.200 |
Why?
|
| Altitude Sickness | 1 | 2004 | 13 | 0.200 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2003 | 5 | 0.200 |
Why?
|
| Hemoglobinopathies | 1 | 2003 | 9 | 0.200 |
Why?
|
| Protein Isoforms | 2 | 2015 | 303 | 0.200 |
Why?
|
| Sulfides | 2 | 2014 | 72 | 0.200 |
Why?
|
| Neuroblastoma | 3 | 2016 | 409 | 0.200 |
Why?
|
| Nuclear Proteins | 3 | 2004 | 750 | 0.190 |
Why?
|
| Proteins | 1 | 2008 | 804 | 0.190 |
Why?
|
| Diaphragm | 4 | 2001 | 76 | 0.190 |
Why?
|
| Cytosol | 3 | 2000 | 193 | 0.190 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2009 | 308 | 0.190 |
Why?
|
| Insulin Resistance | 3 | 2020 | 391 | 0.190 |
Why?
|
| Cadmium Chloride | 3 | 2012 | 12 | 0.190 |
Why?
|
| Analysis of Variance | 5 | 2011 | 889 | 0.190 |
Why?
|
| Urethane | 1 | 2022 | 5 | 0.190 |
Why?
|
| Mole Rats | 1 | 2022 | 6 | 0.180 |
Why?
|
| Protein Phosphatase 1 | 1 | 2022 | 31 | 0.180 |
Why?
|
| Periodicity | 1 | 2003 | 115 | 0.180 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 1999 | 30 | 0.180 |
Why?
|
| Hypoglossal Nerve | 5 | 2023 | 28 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2011 | 1950 | 0.180 |
Why?
|
| Aconitate Hydratase | 2 | 2016 | 11 | 0.180 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 86 | 0.170 |
Why?
|
| Receptor, Endothelin A | 2 | 2013 | 21 | 0.170 |
Why?
|
| Splanchnic Nerves | 2 | 2014 | 8 | 0.170 |
Why?
|
| Heterozygote | 3 | 2020 | 390 | 0.170 |
Why?
|
| Carotid Arteries | 2 | 2019 | 132 | 0.160 |
Why?
|
| Potassium | 6 | 2007 | 230 | 0.160 |
Why?
|
| Gene Silencing | 1 | 2021 | 178 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type I | 4 | 2002 | 22 | 0.160 |
Why?
|
| Adenosine | 4 | 1994 | 291 | 0.160 |
Why?
|
| Glycopeptides | 3 | 2000 | 18 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2014 | 220 | 0.160 |
Why?
|
| Plethysmography, Whole Body | 3 | 2011 | 9 | 0.150 |
Why?
|
| Electric Stimulation | 8 | 2011 | 340 | 0.150 |
Why?
|
| Immunoblotting | 2 | 2013 | 274 | 0.150 |
Why?
|
| NADH Dehydrogenase | 1 | 2018 | 22 | 0.140 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 68 | 0.140 |
Why?
|
| Muscles | 3 | 2014 | 179 | 0.140 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 83 | 0.140 |
Why?
|
| ERG1 Potassium Channel | 3 | 2015 | 14 | 0.140 |
Why?
|
| Pyrimidines | 1 | 2021 | 413 | 0.140 |
Why?
|
| Blotting, Western | 3 | 2011 | 780 | 0.140 |
Why?
|
| Receptors, Drug | 1 | 1998 | 51 | 0.140 |
Why?
|
| omega-Conotoxins | 1 | 1997 | 2 | 0.130 |
Why?
|
| Aortic Bodies | 2 | 2003 | 2 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 209 | 0.130 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 2011 | 64 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2003 | 119 | 0.130 |
Why?
|
| Digoxin | 2 | 2020 | 21 | 0.130 |
Why?
|
| Indazoles | 2 | 2011 | 63 | 0.130 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 1565 | 0.130 |
Why?
|
| Rats, Inbred SHR | 1 | 2017 | 33 | 0.130 |
Why?
|
| Rats, Inbred WKY | 1 | 2017 | 31 | 0.130 |
Why?
|
| Tidal Volume | 7 | 2005 | 65 | 0.130 |
Why?
|
| Cell Line | 3 | 2009 | 2483 | 0.130 |
Why?
|
| Nicotine | 3 | 2010 | 218 | 0.130 |
Why?
|
| Genes, jun | 2 | 1996 | 18 | 0.120 |
Why?
|
| Capsaicin | 3 | 1993 | 43 | 0.120 |
Why?
|
| Tissue Distribution | 2 | 2014 | 290 | 0.120 |
Why?
|
| Glutathione Peroxidase | 1 | 2016 | 26 | 0.120 |
Why?
|
| Catalase | 1 | 2016 | 46 | 0.120 |
Why?
|
| Serotonin Antagonists | 2 | 2006 | 24 | 0.120 |
Why?
|
| Peroxiredoxins | 1 | 2016 | 13 | 0.120 |
Why?
|
| Systems Biology | 1 | 2017 | 51 | 0.120 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2016 | 35 | 0.120 |
Why?
|
| Ion Channel Gating | 1 | 1999 | 318 | 0.120 |
Why?
|
| Cell Membrane | 3 | 2005 | 673 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2016 | 1394 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 435 | 0.120 |
Why?
|
| Nodose Ganglion | 1 | 1996 | 1 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1998 | 298 | 0.120 |
Why?
|
| Ketanserin | 2 | 2006 | 9 | 0.120 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 393 | 0.120 |
Why?
|
| Benzeneacetamides | 1 | 2015 | 13 | 0.120 |
Why?
|
| History, 20th Century | 2 | 2010 | 323 | 0.120 |
Why?
|
| Mixed Function Oxygenases | 3 | 2014 | 68 | 0.110 |
Why?
|
| Nisoldipine | 3 | 2000 | 5 | 0.110 |
Why?
|
| Cell Survival | 3 | 2004 | 1014 | 0.110 |
Why?
|
| Solitary Nucleus | 2 | 2014 | 23 | 0.110 |
Why?
|
| Essential Hypertension | 1 | 2015 | 10 | 0.110 |
Why?
|
| Adrenal Cortex | 2 | 2012 | 20 | 0.110 |
Why?
|
| Cell Line, Tumor | 5 | 2026 | 2892 | 0.110 |
Why?
|
| Heme | 1 | 2015 | 66 | 0.110 |
Why?
|
| Deferoxamine | 2 | 2011 | 19 | 0.110 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 118 | 0.110 |
Why?
|
| Sulfonamides | 3 | 2004 | 351 | 0.110 |
Why?
|
| Siderophores | 2 | 2011 | 21 | 0.110 |
Why?
|
| Endothelium, Vascular | 1 | 2017 | 440 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2026 | 2373 | 0.110 |
Why?
|
| Acute Disease | 2 | 2006 | 860 | 0.110 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 190 | 0.100 |
Why?
|
| Mice, Mutant Strains | 3 | 2011 | 217 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 2784 | 0.100 |
Why?
|
| Insulin-Secreting Cells | 2 | 2020 | 453 | 0.100 |
Why?
|
| Cysteine | 1 | 2015 | 149 | 0.100 |
Why?
|
| Aging | 2 | 2008 | 770 | 0.100 |
Why?
|
| Hyperinsulinism | 1 | 2014 | 44 | 0.100 |
Why?
|
| Cerebellum | 1 | 1996 | 253 | 0.100 |
Why?
|
| Fibroblasts | 3 | 2011 | 767 | 0.100 |
Why?
|
| Neuropeptide Y | 2 | 2011 | 29 | 0.100 |
Why?
|
| Intercellular Junctions | 1 | 2014 | 69 | 0.100 |
Why?
|
| Vasodilation | 1 | 2014 | 91 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 1286 | 0.100 |
Why?
|
| Endothelin-Converting Enzymes | 1 | 2013 | 4 | 0.100 |
Why?
|
| Pyridines | 1 | 2015 | 318 | 0.100 |
Why?
|
| Biomedical Research | 2 | 2009 | 471 | 0.100 |
Why?
|
| Interleukins | 1 | 2014 | 135 | 0.100 |
Why?
|
| Reference Values | 3 | 2002 | 608 | 0.100 |
Why?
|
| Cold Temperature | 5 | 1989 | 163 | 0.100 |
Why?
|
| Electric Impedance | 1 | 2014 | 118 | 0.100 |
Why?
|
| Software | 1 | 2018 | 693 | 0.100 |
Why?
|
| Rats, Wistar | 1 | 2014 | 304 | 0.100 |
Why?
|
| Neurokinin A | 2 | 1990 | 12 | 0.090 |
Why?
|
| Polysomnography | 1 | 2013 | 154 | 0.090 |
Why?
|
| Protoporphyrins | 3 | 1998 | 18 | 0.090 |
Why?
|
| Cytoskeleton | 1 | 2014 | 200 | 0.090 |
Why?
|
| Nifedipine | 1 | 2012 | 24 | 0.090 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2012 | 12 | 0.090 |
Why?
|
| Body Weight | 1 | 2014 | 455 | 0.090 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2012 | 14 | 0.090 |
Why?
|
| Multienzyme Complexes | 2 | 2011 | 54 | 0.090 |
Why?
|
| Arousal | 1 | 2013 | 177 | 0.090 |
Why?
|
| Erythropoiesis | 1 | 2012 | 53 | 0.090 |
Why?
|
| Synaptic Transmission | 2 | 2012 | 226 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 1 | 1993 | 143 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2012 | 92 | 0.090 |
Why?
|
| Species Specificity | 1 | 2014 | 690 | 0.090 |
Why?
|
| Intercostal Muscles | 4 | 1988 | 9 | 0.090 |
Why?
|
| Potassium Channel Blockers | 3 | 2003 | 62 | 0.090 |
Why?
|
| KATP Channels | 1 | 2012 | 18 | 0.090 |
Why?
|
| Aldosterone | 1 | 2012 | 57 | 0.090 |
Why?
|
| Furans | 1 | 2011 | 19 | 0.090 |
Why?
|
| Cadmium | 2 | 2009 | 30 | 0.090 |
Why?
|
| Faculty | 1 | 2011 | 40 | 0.090 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2011 | 23 | 0.090 |
Why?
|
| Indoles | 3 | 2000 | 334 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2004 | 276 | 0.080 |
Why?
|
| Isoenzymes | 3 | 2012 | 272 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1991 | 16 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 3 | 1998 | 9 | 0.080 |
Why?
|
| CpG Islands | 1 | 2012 | 177 | 0.080 |
Why?
|
| Time | 1 | 2011 | 80 | 0.080 |
Why?
|
| Oxidants | 1 | 2011 | 86 | 0.080 |
Why?
|
| Vagotomy | 5 | 2004 | 12 | 0.080 |
Why?
|
| Eledoisin | 1 | 1990 | 1 | 0.080 |
Why?
|
| Physalaemin | 1 | 1990 | 1 | 0.080 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1990 | 24 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2011 | 131 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 3 | 1998 | 1028 | 0.080 |
Why?
|
| Blood Gas Analysis | 3 | 2005 | 35 | 0.080 |
Why?
|
| Kinetics | 3 | 2008 | 1476 | 0.080 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 32 | 0.080 |
Why?
|
| Trachea | 2 | 2008 | 249 | 0.080 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2010 | 34 | 0.080 |
Why?
|
| Guanabenz | 3 | 1998 | 3 | 0.080 |
Why?
|
| Glutathione | 1 | 2010 | 108 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 682 | 0.080 |
Why?
|
| Genomics | 1 | 2016 | 898 | 0.080 |
Why?
|
| Recurrence | 2 | 2004 | 1254 | 0.080 |
Why?
|
| Genetics, Medical | 1 | 2010 | 51 | 0.080 |
Why?
|
| Neoplasms | 1 | 2026 | 3340 | 0.080 |
Why?
|
| Phenethylamines | 2 | 2000 | 7 | 0.080 |
Why?
|
| Acetylcysteine | 2 | 2011 | 73 | 0.080 |
Why?
|
| Enkephalin, Methionine | 2 | 2000 | 5 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2000 | 24 | 0.080 |
Why?
|
| Particulate Matter | 1 | 2011 | 138 | 0.080 |
Why?
|
| Renin-Angiotensin System | 1 | 2010 | 87 | 0.080 |
Why?
|
| Air Pollutants | 1 | 2011 | 116 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2000 | 92 | 0.080 |
Why?
|
| Lung Volume Measurements | 2 | 2008 | 24 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2000 | 84 | 0.080 |
Why?
|
| Sodium Cyanide | 2 | 2004 | 6 | 0.080 |
Why?
|
| Neural Conduction | 2 | 2006 | 72 | 0.080 |
Why?
|
| Hydrolysis | 2 | 2000 | 145 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 237 | 0.080 |
Why?
|
| Protein Phosphatase 2 | 1 | 2009 | 17 | 0.070 |
Why?
|
| Heart Rate | 3 | 2009 | 534 | 0.070 |
Why?
|
| Maleimides | 2 | 2000 | 26 | 0.070 |
Why?
|
| Dinitrophenols | 1 | 1989 | 7 | 0.070 |
Why?
|
| Receptors, Cytokine | 2 | 2022 | 31 | 0.070 |
Why?
|
| Mitochondria, Heart | 1 | 1989 | 51 | 0.070 |
Why?
|
| Staurosporine | 2 | 2000 | 34 | 0.070 |
Why?
|
| Egtazic Acid | 2 | 2000 | 32 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 1110 | 0.070 |
Why?
|
| Extracellular Fluid | 1 | 2009 | 25 | 0.070 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2008 | 9 | 0.070 |
Why?
|
| Hydroxylation | 1 | 2008 | 19 | 0.070 |
Why?
|
| Phospholipase C gamma | 1 | 2008 | 15 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 889 | 0.070 |
Why?
|
| Respiratory Tract Diseases | 1 | 2009 | 45 | 0.070 |
Why?
|
| Spirometry | 1 | 2008 | 78 | 0.070 |
Why?
|
| Elasticity | 1 | 2008 | 98 | 0.070 |
Why?
|
| Thoracic Wall | 1 | 2008 | 26 | 0.070 |
Why?
|
| Anaerobiosis | 1 | 2008 | 21 | 0.070 |
Why?
|
| Autonomic Nervous System | 1 | 2009 | 70 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 122 | 0.070 |
Why?
|
| Ion Transport | 2 | 2000 | 86 | 0.070 |
Why?
|
| Hippocampus | 1 | 2011 | 462 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2008 | 327 | 0.070 |
Why?
|
| Anesthetics, Intravenous | 1 | 2007 | 45 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2009 | 207 | 0.070 |
Why?
|
| Sirolimus | 1 | 2008 | 182 | 0.060 |
Why?
|
| Secretory Vesicles | 1 | 2007 | 42 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2009 | 332 | 0.060 |
Why?
|
| Propofol | 1 | 2007 | 95 | 0.060 |
Why?
|
| Receptors, Neurokinin-1 | 2 | 2000 | 10 | 0.060 |
Why?
|
| Methysergide | 1 | 2006 | 6 | 0.060 |
Why?
|
| Nerve Fibers | 2 | 1986 | 40 | 0.060 |
Why?
|
| Chicago | 1 | 2011 | 1513 | 0.060 |
Why?
|
| Receptors, Serotonin | 1 | 2006 | 34 | 0.060 |
Why?
|
| Acetophenones | 1 | 2006 | 27 | 0.060 |
Why?
|
| Nerve Endings | 1 | 1986 | 15 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2012 | 58 | 0.060 |
Why?
|
| Nociceptors | 1 | 1986 | 28 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 313 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2005 | 20 | 0.060 |
Why?
|
| Enzyme Induction | 2 | 1996 | 83 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2005 | 28 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2006 | 74 | 0.060 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2005 | 11 | 0.060 |
Why?
|
| Radioligand Assay | 2 | 1998 | 32 | 0.060 |
Why?
|
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2005 | 6 | 0.060 |
Why?
|
| Mice, Inbred Strains | 2 | 2011 | 281 | 0.060 |
Why?
|
| Mountaineering | 1 | 2005 | 2 | 0.060 |
Why?
|
| Mesentery | 1 | 1985 | 49 | 0.060 |
Why?
|
| Benzylamines | 1 | 2004 | 17 | 0.050 |
Why?
|
| Asparagine | 1 | 2004 | 27 | 0.050 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2004 | 15 | 0.050 |
Why?
|
| Protein Binding | 1 | 2009 | 1554 | 0.050 |
Why?
|
| Efferent Pathways | 2 | 2000 | 22 | 0.050 |
Why?
|
| Muscle Contraction | 2 | 2001 | 269 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2000 | 977 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2004 | 239 | 0.050 |
Why?
|
| Spinal Cord | 1 | 1986 | 243 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 116 | 0.050 |
Why?
|
| Wakefulness | 1 | 2005 | 128 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2004 | 93 | 0.050 |
Why?
|
| Pons | 1 | 2004 | 25 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2004 | 71 | 0.050 |
Why?
|
| Plasmids | 1 | 2004 | 275 | 0.050 |
Why?
|
| Vasomotor System | 3 | 1988 | 13 | 0.050 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2024 | 28 | 0.050 |
Why?
|
| Pediatrics | 1 | 2009 | 421 | 0.050 |
Why?
|
| Models, Neurological | 2 | 1999 | 411 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 285 | 0.050 |
Why?
|
| Electron Transport Complex III | 1 | 2003 | 13 | 0.050 |
Why?
|
| Receptors, Dopamine | 1 | 2003 | 32 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 212 | 0.050 |
Why?
|
| Receptors, Muscarinic | 1 | 2003 | 42 | 0.050 |
Why?
|
| Thoracotomy | 1 | 2004 | 71 | 0.050 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 1994 | 30 | 0.050 |
Why?
|
| omega-Conotoxin GVIA | 2 | 2005 | 8 | 0.050 |
Why?
|
| Metallothionein | 1 | 2022 | 12 | 0.050 |
Why?
|
| Serine | 1 | 2003 | 106 | 0.050 |
Why?
|
| Lysine | 1 | 2024 | 181 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 571 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2019 | 911 | 0.050 |
Why?
|
| Respiration, Artificial | 3 | 2004 | 462 | 0.050 |
Why?
|
| Aorta | 2 | 2022 | 275 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2004 | 615 | 0.050 |
Why?
|
| Risk Factors | 1 | 2013 | 6233 | 0.040 |
Why?
|
| United States | 3 | 2010 | 8197 | 0.040 |
Why?
|
| Aminoquinolines | 2 | 1999 | 21 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 1986 | 416 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2002 | 163 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 2001 | 113 | 0.040 |
Why?
|
| Muscle Fatigue | 1 | 2001 | 23 | 0.040 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2001 | 17 | 0.040 |
Why?
|
| HEPES | 1 | 2000 | 1 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2001 | 92 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2000 | 122 | 0.040 |
Why?
|
| Calcium Channel Agonists | 1 | 2000 | 13 | 0.040 |
Why?
|
| Extracellular Space | 1 | 2000 | 84 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2019 | 1790 | 0.040 |
Why?
|
| Barium | 1 | 2000 | 32 | 0.040 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2001 | 59 | 0.040 |
Why?
|
| Genotype | 1 | 2005 | 1888 | 0.040 |
Why?
|
| Okadaic Acid | 1 | 2000 | 10 | 0.040 |
Why?
|
| Buffers | 1 | 2000 | 24 | 0.040 |
Why?
|
| Genome | 1 | 2003 | 417 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2000 | 68 | 0.040 |
Why?
|
| Acetylcholinesterase | 2 | 2003 | 42 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2000 | 70 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 123 | 0.040 |
Why?
|
| Point Mutation | 1 | 2000 | 237 | 0.040 |
Why?
|
| Dithionite | 1 | 1999 | 3 | 0.040 |
Why?
|
| Ethylmaleimide | 1 | 1999 | 13 | 0.040 |
Why?
|
| Cyanides | 1 | 1999 | 16 | 0.040 |
Why?
|
| Nitroprusside | 1 | 1999 | 25 | 0.040 |
Why?
|
| Nitrites | 1 | 1999 | 34 | 0.040 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 1999 | 6 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2002 | 448 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 218 | 0.040 |
Why?
|
| DNA | 1 | 2004 | 1274 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 1998 | 23 | 0.040 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1998 | 9 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 409 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 564 | 0.040 |
Why?
|
| Imidazoline Receptors | 1 | 1998 | 2 | 0.040 |
Why?
|
| Affinity Labels | 1 | 1998 | 9 | 0.030 |
Why?
|
| Aspartic Acid | 2 | 1989 | 62 | 0.030 |
Why?
|
| Autoradiography | 1 | 1998 | 51 | 0.030 |
Why?
|
| Drug Interactions | 2 | 2011 | 239 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 1999 | 134 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 890 | 0.030 |
Why?
|
| Membranes | 1 | 1998 | 35 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2000 | 185 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 1998 | 165 | 0.030 |
Why?
|
| Clonidine | 1 | 1998 | 33 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 304 | 0.030 |
Why?
|
| Microelectrodes | 1 | 1998 | 88 | 0.030 |
Why?
|
| Body Temperature | 1 | 1998 | 127 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 595 | 0.030 |
Why?
|
| Heart Failure | 2 | 2011 | 1491 | 0.030 |
Why?
|
| omega-Agatoxin IVA | 1 | 1997 | 2 | 0.030 |
Why?
|
| Spider Venoms | 1 | 1997 | 10 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1998 | 145 | 0.030 |
Why?
|
| Nitroarginine | 2 | 1995 | 16 | 0.030 |
Why?
|
| NADPH Dehydrogenase | 2 | 1995 | 11 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2017 | 21 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 257 | 0.030 |
Why?
|
| Glucose | 1 | 2020 | 704 | 0.030 |
Why?
|
| Arginine | 2 | 1995 | 143 | 0.030 |
Why?
|
| Adult | 3 | 2019 | 29539 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 45 | 0.030 |
Why?
|
| Muscarinic Agonists | 1 | 1996 | 22 | 0.030 |
Why?
|
| Chloride Channels | 1 | 1996 | 43 | 0.030 |
Why?
|
| Atmospheric Pressure | 1 | 1996 | 3 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 198 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1996 | 34 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 521 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 1995 | 21 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1995 | 25 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1995 | 31 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 2013 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 592 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1782 | 0.030 |
Why?
|
| Microsomes | 1 | 1995 | 32 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1995 | 62 | 0.030 |
Why?
|
| Atropine | 2 | 2003 | 53 | 0.030 |
Why?
|
| Cattle | 1 | 1995 | 397 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 129 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1996 | 234 | 0.030 |
Why?
|
| Dopamine Antagonists | 2 | 2005 | 33 | 0.030 |
Why?
|
| Immediate-Early Proteins | 1 | 1996 | 161 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1995 | 228 | 0.030 |
Why?
|
| Dendrites | 1 | 1995 | 98 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 903 | 0.030 |
Why?
|
| Receptors, Tachykinin | 1 | 1994 | 8 | 0.030 |
Why?
|
| Sodium Bicarbonate | 1 | 1994 | 10 | 0.030 |
Why?
|
| Peptides | 1 | 1997 | 669 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 922 | 0.030 |
Why?
|
| Response Elements | 1 | 2014 | 68 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2007 | 423 | 0.030 |
Why?
|
| Sympathectomy | 1 | 1994 | 20 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1993 | 9 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 1994 | 72 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1998 | 640 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 1993 | 102 | 0.020 |
Why?
|
| Neuropeptides | 1 | 1994 | 113 | 0.020 |
Why?
|
| Cytosine | 1 | 2014 | 124 | 0.020 |
Why?
|
| Adrenergic alpha-2 Receptor Antagonists | 1 | 1993 | 3 | 0.020 |
Why?
|
| Glucagon | 1 | 2013 | 114 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2014 | 134 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2005 | 87 | 0.020 |
Why?
|
| Myocardium | 1 | 1996 | 578 | 0.020 |
Why?
|
| Proinsulin | 1 | 2013 | 123 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1993 | 42 | 0.020 |
Why?
|
| Computational Biology | 1 | 2016 | 614 | 0.020 |
Why?
|
| Mechanoreceptors | 2 | 1988 | 18 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1996 | 551 | 0.020 |
Why?
|
| Cytochrome P-450 CYP11B2 | 1 | 2012 | 3 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2012 | 5 | 0.020 |
Why?
|
| Receptors, Angiotensin | 1 | 2012 | 11 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2012 | 26 | 0.020 |
Why?
|
| Decerebrate State | 2 | 1989 | 4 | 0.020 |
Why?
|
| Anesthesia | 1 | 1994 | 175 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2012 | 41 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 42 | 0.020 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2011 | 14 | 0.020 |
Why?
|
| Picrotoxin | 1 | 2011 | 7 | 0.020 |
Why?
|
| Ferrous Compounds | 1 | 2011 | 18 | 0.020 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2011 | 36 | 0.020 |
Why?
|
| GABA Antagonists | 1 | 2011 | 26 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 46 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1973 | 261 | 0.020 |
Why?
|
| Heart Ventricles | 2 | 2011 | 664 | 0.020 |
Why?
|
| Bradycardia | 1 | 2011 | 51 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2011 | 78 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1991 | 30 | 0.020 |
Why?
|
| Superior Cervical Ganglion | 1 | 2011 | 3 | 0.020 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2011 | 6 | 0.020 |
Why?
|
| Cathepsin L | 1 | 2011 | 7 | 0.020 |
Why?
|
| Carboxypeptidase H | 1 | 2011 | 12 | 0.020 |
Why?
|
| Biophysics | 1 | 2011 | 154 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1988 | 300 | 0.020 |
Why?
|
| Proprotein Convertase 1 | 1 | 2011 | 11 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2011 | 15 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 2080 | 0.020 |
Why?
|
| Receptors, Neurokinin-2 | 1 | 1990 | 3 | 0.020 |
Why?
|
| Ganglia, Autonomic | 2 | 2005 | 6 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 820 | 0.020 |
Why?
|
| Sudden Infant Death | 1 | 1991 | 36 | 0.020 |
Why?
|
| Apoptosis | 1 | 2007 | 1752 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1991 | 133 | 0.020 |
Why?
|
| Chemotaxis | 1 | 1990 | 77 | 0.020 |
Why?
|
| Electromyography | 2 | 1988 | 233 | 0.020 |
Why?
|
| Pressure | 2 | 1985 | 173 | 0.020 |
Why?
|
| Biguanides | 2 | 1986 | 5 | 0.020 |
Why?
|
| Succinic Acid | 1 | 1989 | 11 | 0.020 |
Why?
|
| Succinates | 1 | 1989 | 29 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 1989 | 61 | 0.020 |
Why?
|
| Piperazines | 1 | 2011 | 306 | 0.020 |
Why?
|
| Silver Nitrate | 1 | 1989 | 2 | 0.020 |
Why?
|
| 2,4-Dinitrophenol | 1 | 1989 | 3 | 0.020 |
Why?
|
| Spinal Nerves | 1 | 1988 | 2 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2009 | 28 | 0.020 |
Why?
|
| Cranial Nerves | 1 | 1988 | 9 | 0.020 |
Why?
|
| Amidine-Lyases | 1 | 2008 | 2 | 0.020 |
Why?
|
| Solubility | 1 | 1989 | 187 | 0.020 |
Why?
|
| Somatostatin | 1 | 1988 | 61 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 1986 | 85 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2008 | 99 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 4116 | 0.020 |
Why?
|
| Naloxone | 1 | 1988 | 80 | 0.020 |
Why?
|
| Muscle Spindles | 1 | 1988 | 4 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 141 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 1987 | 33 | 0.020 |
Why?
|
| Kainic Acid | 1 | 1987 | 23 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 1987 | 40 | 0.020 |
Why?
|
| Lobeline | 1 | 1986 | 4 | 0.020 |
Why?
|
| Hexamethonium Compounds | 1 | 1986 | 6 | 0.020 |
Why?
|
| Hexamethonium | 1 | 1986 | 4 | 0.020 |
Why?
|
| Administration, Topical | 1 | 1986 | 80 | 0.020 |
Why?
|
| Anesthesia, Local | 1 | 1986 | 29 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1987 | 299 | 0.020 |
Why?
|
| Lidocaine | 1 | 1986 | 62 | 0.010 |
Why?
|
| Butaclamol | 1 | 2005 | 1 | 0.010 |
Why?
|
| Sulpiride | 1 | 2005 | 2 | 0.010 |
Why?
|
| Dantrolene | 1 | 2005 | 5 | 0.010 |
Why?
|
| Nimodipine | 1 | 2005 | 12 | 0.010 |
Why?
|
| Nerve Growth Factor | 1 | 2005 | 19 | 0.010 |
Why?
|
| Boron Compounds | 1 | 2005 | 17 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2005 | 56 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 220 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 2005 | 5 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 1985 | 48 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 2005 | 19 | 0.010 |
Why?
|
| Abdominal Muscles | 1 | 1985 | 26 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2005 | 56 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 193 | 0.010 |
Why?
|
| Caffeine | 1 | 2005 | 86 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 373 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2003 | 13 | 0.010 |
Why?
|
| Domperidone | 1 | 2003 | 7 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1985 | 318 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 2003 | 60 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 7389 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 2002 | 39 | 0.010 |
Why?
|
| Renin | 1 | 1982 | 69 | 0.010 |
Why?
|
| Urinary Bladder Diseases | 1 | 1982 | 40 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2002 | 137 | 0.010 |
Why?
|
| Calcium Channels, N-Type | 1 | 2001 | 40 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 291 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2002 | 368 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2001 | 239 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2005 | 1646 | 0.010 |
Why?
|
| 2-Amino-5-phosphonovalerate | 2 | 1989 | 11 | 0.010 |
Why?
|
| N-Methylaspartate | 2 | 1989 | 45 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 668 | 0.010 |
Why?
|
| Pregnancy | 1 | 2005 | 3244 | 0.010 |
Why?
|
| Aged | 2 | 2014 | 21758 | 0.010 |
Why?
|
| Child | 1 | 2009 | 7681 | 0.010 |
Why?
|
| Methylene Blue | 1 | 1996 | 18 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1996 | 19 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1996 | 58 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1996 | 161 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1996 | 68 | 0.010 |
Why?
|
| Muscimol | 2 | 1986 | 18 | 0.010 |
Why?
|
| Middle Aged | 2 | 2014 | 29428 | 0.010 |
Why?
|
| Temperature | 2 | 1987 | 442 | 0.010 |
Why?
|
| Pentolinium Tartrate | 1 | 1973 | 1 | 0.010 |
Why?
|
| Reserpine | 1 | 1973 | 5 | 0.010 |
Why?
|
| Dilatation | 1 | 1973 | 46 | 0.010 |
Why?
|
| Dogs | 1 | 1973 | 639 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1992 | 212 | 0.010 |
Why?
|
| Vertebral Artery | 1 | 1992 | 33 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1992 | 93 | 0.010 |
Why?
|
| Dipyridamole | 1 | 1989 | 12 | 0.000 |
Why?
|
| Aminophylline | 1 | 1989 | 13 | 0.000 |
Why?
|
| Glossopharyngeal Nerve | 1 | 1988 | 1 | 0.000 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 1988 | 15 | 0.000 |
Why?
|
| Breath Tests | 1 | 1988 | 59 | 0.000 |
Why?
|
| Nerve Block | 1 | 1988 | 55 | 0.000 |
Why?
|
| Cervical Plexus | 1 | 1987 | 3 | 0.000 |
Why?
|
| Quisqualic Acid | 1 | 1987 | 1 | 0.000 |
Why?
|
| Valine | 1 | 1987 | 48 | 0.000 |
Why?
|
| Glutamates | 1 | 1987 | 84 | 0.000 |
Why?
|
| Chloralose | 1 | 1986 | 5 | 0.000 |
Why?
|
| Anesthesia, General | 1 | 1986 | 130 | 0.000 |
Why?
|